Table 4.
Review of previous studies on endovascular treatment of tandem occlusion of internal carotid/middle cerebral artery.
| Studies | n | Age, Years, Range | NIHSS at Admission | IV t–PA (%) | Carotid Stent | Successful Recanalization | ICH | Mortality | Good Functional Outcome at 3 Months |
|---|---|---|---|---|---|---|---|---|---|
| Current Study | 53 | 75.9 (64.6–82.6) | 18 (16–22) | 37 (69.8) | 7 (13.2) | 36 (67.9) | 14 (28.0) | 15 (28.3) | 20 (37.8) |
| Sallustio et al. [10] | 72 | 65.6 ± 12.8 | 19 ± 2.9 | 39 (54.1) | 35 (48.6) | 46 (64.0) | 9 (12.5) | 23 (31.9) | 23 (31.9) |
| Heck et al. [24] | 23 | 70 (45–86) | 17 (9–25) | 12 (52.0) | 23 (100.0) | 17 (74.0) | 5 (22.0) | 9 (39.0) | 12 (52.0) |
| Malik et al. [27] | 77 | 63.4 ± 10.9 | 14.8 ± 5.4 | - | 77 (100.0) | 58 (75.3) | 8 (10.4) | 19 (24.7) | 32 (41.6) |
| Behme et al. [11] | 170 | 64 (25–88) | 15 (12–19) | 122 (72.0) | 180 (100.0) | 130 (77.0) | 15 (9.0) | 32 (19) | 61 (36.0) |
| Cohen et al. [28] | 24 | 66 (51–77) | 20.4 (14–28) | 10 (41.6) | 24 (100.0) | 19 (79.0) | 6 (25.0) | 2 (8) | 13 (76) |
| Lockau et al. [29] | 37 | 63 (36–89) | 17 (3–30) | 20 (54.1) | 37 (100.0) | 27 (73.0) | 4 (10.8) | 7 (18.9) | 17 (45.9) |
| Puri et al. [30] | 28 | 58.7 (30–83) | 18 (15–22) | 8 (27.3) | 28 (100.0) | 20 (71.4) | 2 (7.1) | 4 (14.3) | 11 (39.3) |
| Lescher et al. [31] | 39 | 68 (38–92) | 14 (6–20) | 20 (74.0) | 39 (100.0) | 25 (64.0) | 4 (10.0) | 4 (10.0) | 14 (36) |
| Stampfl et al. [32] | 24 | 67 (49–83) | 18 (15–22) | NA | 24 (100.0) | 15 (62.5) | 1 (4.2) | 4 (16.6) | 7 (29.2) |
Numbers in parentheses are percentages, except age in years, which is given as median with interquartile range or mean with standard deviation. NIHSS—National Institutes of Health Stroke Scale; t-PA—intravenous thrombolysis with recombinant tissue plasminogen activator; ICH—intracerebral hemorrhage; NA—not available. Successful recanalization defined as thrombolysis in cerebral infarction (TICI) grade 2b or 3.